FeNO After Hypoxia in Asthma Patients
NCT02391090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2015-03-18
Summary
Stable Asthma patients (GINA 1-2) stay 6 days in a row for 4 hours per day in a hypoxic chamber simulating 2800m above sea level. Study participants will be blinded to the treatment given and divided into a hypoxic and a sham group (about 360m above sea level).
Effects of this intermittent hypoxia on the asthmatic inflammation of these patients will be measured. The primary endpoint is the change in forced exhaled nitric oxide (FeNO) before and after the study. Secondary endpoints include blood parameters, lung function testing and questionnaires.
Conditions
Interventions
- DEVICE
-
hypoxia in hypoxic chamber
Intervention lasts 4 hours per day for 6 days in a row.
- DEVICE
-
sham hypoxia in hypoxic chamber
Intervention lasts 4 hours per day for 6 days in a row.
- PROCEDURE
-
Pulse oximetry
Pulse oximetry will be performed hourly during sessions in the hypoxic chamber for safety reasons.
- OTHER
-
Asthma and Quality of Life Questionnaires
Before every session in the hypoxic chamber as well as on the day after the last session will be completed.
- PROCEDURE
-
Lung function testing
On the day of the first session in the hypoxic chamber as well as on the day after the last session lung function testing will be performed.
- PROCEDURE
-
Blood taking
On the day of the first session in the hypoxic chamber as well as on the day after the last session blood samples will be taken.
- PROCEDURE
-
FeNO measurement
Before every session in the hypoxic chamber as well as on the day after the last session FeNO (forced exhaled nitric oxide) measurement will be performed.
Sponsors & Collaborators
-
Ludwig Boltzmann Institute for Lung Vascular Research
collaborator OTHER -
Medical University of Graz
lead OTHER
Principal Investigators
-
Horst Olschewski, MD, Prof. · Medical University of Graz, Department of Internal Medicine, Division of Pulmonology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- Austria
Study Locations
More Related Trials
-
Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age
NCT01729247 ·Status: COMPLETED
-
Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)
NCT00686309 ·Status: UNKNOWN
-
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
NCT04450108 ·Status: COMPLETED ·Phase: NA
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma
NCT01648920 ·Status: COMPLETED
-
Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma
NCT02566902 ·Status: COMPLETED ·Phase: NA
-
Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
NCT02561351 ·Status: COMPLETED
-
The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma
NCT00262340 ·Status: COMPLETED ·Phase: NA
-
GSNOR Phenotyping/GSNO Challenge in Severe Asthma
NCT03926741 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma
NCT05992519 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of Asthma
NCT05603494 ·Status: UNKNOWN ·Phase: NA
-
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NCT06317909 ·Status: RECRUITING ·Phase: NA
-
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
NCT01518322 ·Status: COMPLETED
-
Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children
NCT00515775 ·Status: COMPLETED
-
Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations
NCT02464995 ·Status: UNKNOWN ·Phase: NA
-
Exhaled Nitric Oxide in Asthma Management
NCT02140684 ·Status: SUSPENDED
-
Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct
NCT01426893 ·Status: COMPLETED
-
Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma
NCT03573284 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging
NCT01378624 ·Status: COMPLETED ·Phase: NA
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma Attacks
NCT05870215 ·Status: COMPLETED
-
Monitoring Asthma Treatment Using Exhaled Nitric Oxide
NCT00562991 ·Status: COMPLETED
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Smartphone Enabled Detection of Nocturnal Cough Rate and Sleep Quality as a Prognostic Marker for Asthma Control
NCT03635710 ·Status: COMPLETED